• Elizabeth Nethery, Michael R Law, Andrew Kotaska, Patricia A Janssen, and Jennifer A Hutcheon.
• School of Population and Public Health (Nethery, Law, Kotaska, Janssen, Hutcheon), The University of British Columbia; Centre for Health Services and Policy Research (Law), The University of British Columbia, Vancouver, BC; Department of Obstetrics & Gynecology (Kotaska), University of Manitoba, Winnipeg, Man.; British Columbia Children's Hospital Research Institute (Janssen); Department of Obstetrics & Gynaecology (Hutcheon), The University of British Columbia, Vancouver, BC elizabeth.nethery@alumni.ubc.ca.
• CMAJ. 2023 Mar 20; 195 (11): E396E403E396-E403.

BackgroundRates of gestational diabetes are reported to be increasing in many jurisdictions, but the reasons for this are poorly understood. We sought to evaluate the relative contribution of screening practices for gestational diabetes (including completion and methods of screening) and population characteristics to risk of gestational diabetes in British Columbia, Canada, from 2005 to 2019.MethodsWe used a population-based cohort from a provincial registry of perinatal data, linked to laboratory billing records. We used data on screening completion, screening method (1-step 75-g glucose test or 2-step approach of 50-g glucose screening test, followed by a diagnostic test for patients who screen positive) and demographic risk factors. We modelled predicted annual risk for gestational diabetes, sequentially adjusted for screening completion, screening method and risk factors.ResultsWe included 551 457 pregnancies in the study cohort. The incidence of gestational diabetes more than doubled over the study period, from 7.2% in 2005 to 14.7% in 2019. Screening completion increased from 87.2% in 2005 to 95.5% in 2019. Use of 1-step screening methods increased from 0.0% in 2005 to 39.5% in 2019 among those who were screened. Unadjusted models estimated a 2.04 (95% confidence interval [CI] 1.94-2.13) increased risk of gestational diabetes in 2019 (v. 2005). This increase was 1.89 (95% CI 1.81-1.98) after accounting for the rise in screening completion and 1.34 (95% CI 1.28-1.40) after accounting for changes in screening methods. Further accounting for demographic risk factors (e.g., age, body mass index, prenatal care) had a small impact (increase of 1.25, 95% CI 1.19-1.31).InterpretationMost of the observed increase in the incidence of gestational diabetes was attributable to changes in screening practices (primarily changes in screening methods) rather than changing population factors. Our findings highlight the importance of understanding variation in screening practices when monitoring incidence rates for gestational diabetes.© 2023 CMA Impact Inc. or its licensors.

24 keywords...

hide…